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Schwann cells are the myelinating glia of the peripheral nervous
system. Neuron–Schwann cell contact profoundly affects sev-
eral aspects of Schwann cell phenotype, including stimulation
of mitosis and myelin formation. Many reports suggest that
neuronal contact exerts this influence on Schwann cells by
elevating Schwann cell cAMP and activating cAMP-dependent
protein kinase A (PKA). To elucidate the importance of Schwann
cell PKA in neuronal stimulation of Schwann cell mitosis and
myelination, the gene encoding the PKA inhibitory protein
RIaAB or PKIEGFP was delivered to Schwann cells using ret-
roviral vectors. PKA inhibitory retroviral vectors effectively
blocked forskolin-stimulated Schwann cell mitosis and mor-
phological change, demonstrating the ability of the vectors to
inhibit PKA in infected Schwann cells. Treatment of dorsal root
ganglia neuron–Schwann cell cocultures with H-89 (10 mM) or
KT5720 (1–10 mM), chemical inhibitors selective for PKA, sig-
nificantly inhibited neuronal stimulation of Schwann cell mito-
sis. In contrast, retrovirus-mediated inhibition of Schwann cell
PKA had no effect on the ability of neurons to stimulate
Schwann cell mitosis. However, markedly fewer myelin seg-
ments were formed by Schwann cells expressing PKA inhibi-
tory proteins compared with controls. These results suggest
that activation of Schwann cell PKA is required for myelin
formation but not for Schwann cell mitosis stimulated by inter-
action with neurons.
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Interaction between neurons and Schwann cells in the peripheral
nervous system has many effects on Schwann cell phenotype,
including elevation of Schwann cell mitotic rate (McCarthy and
Partlow, 1976; Salzer and Bunge, 1980; Salzer et al., 1980) and
expression of proteins and lipids critical for myelin formation
(Politis et al., 1982; Sobue and Pleasure, 1984; Sobue et al., 1986;
Shuman et al., 1988; Gupta et al., 1990, 1993; Mirsky et al., 1990;
Morgan et al., 1991; Fernandez-Valle et al., 1993). Schwann cell
division stimulated by neuron–Schwann cell interactions is crit-
ical during both normal development and regeneration after
nerve damage (Bunge, 1994). The normal development of myelin
by Schwann cells is essential to the proper function of the periph-
eral nervous system. Disruption of myelin formation results in
significant peripheral neuropathies in humans, such as Charcot-
Marie-Tooth disease (Hayasaka et al., 1993; Kulkens et al., 1993;
Oh et al., 1997; Marrosu et al., 1998). Hence, a detailed under-
standing of the molecular mechanisms responsible for neuronal
modulation of Schwann cell phenotype is essential for elucidating
the etiology of many peripheral neuropathies, as well as to facil-
itate regeneration after peripheral nerve damage. Despite its
critical nature, the molecular mechanisms mediating the neuron–
Schwann cell interaction are only beginning to be understood.
Mitosis and myelination are among several Schwann cell prop-
erties modulated in a similar manner by neuron–Schwann cell
contact or treatment of cultured Schwann cells with cAMP-
elevating agents. These results suggest that neuronal contact may
stimulate Schwann cell mitosis and myelin formation by elevating
Schwann cell cAMP and activating the cAMP-dependent protein
kinase A (PKA). However, Schwann cells must first be quiescent
for cAMP elevation to promote the myelinating phenotype (Mor-
gan et al., 1991). This observation suggests that, as Schwann cells
differentiate into the myelinating lineage, their response to
cAMP elevation may change from mitosis to induction of a
myelin-related phenotype. Our studies were designed to test the
hypothesis that Schwann cell PKA plays a critical role in the
neuronal stimulation of Schwann cell mitosis and myelination.
To investigate the importance of Schwann cell PKA in neuron–
Schwann cell interactions, it is necessary to meet three basic
criteria. First, PKA must be effectively inhibited. Second, inhibi-
tion must be specific for PKA. Third, the inhibition must be
directed specifically to Schwann cells contacting neurons. In con-
sideration of these criteria, we have used retroviral vectors to
deliver genes encoding the PKA inhibitory proteins RIaAB or
PKIEGFP specifically to Schwann cells in coculture with neurons
from dorsal root ganglia (DRG). The dominant negative PKA
regulatory subunit RIaAB has mutations in the two regulatory
subunit cAMP binding sites. These mutations prevent cAMP
binding to the regulatory subunit and consequently block release
of the PKA catalytic subunit in response to elevation of cAMP
concentration (McKnight et al., 1988; Corell et al., 1989; Wood-
ford et al., 1989). PKIEGFP is the full-length rabbit skeletal
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muscle PKIa fused to the N terminus of the green fluorescent
protein EGFP (Wang and Murphy, 1998). The ability of forskolin
to stimulate mitosis and morphological changes in infected
Schwann cells was examined to confirm inhibition of PKA. The
role of Schwann cell PKA in neuronal stimulation of Schwann cell
mitosis and myelination was then examined. Our results suggest
an important role for Schwann cell PKA in myelination but not in
neuronal stimulation of Schwann cell mitosis.
MATERIALS AND METHODS
Dorsal root ganglia explant cultures. Culture surfaces were pretreated for
60 min with a 1:25 dilution of Matrigel (Collaborative Research, Bed-
ford, MA) in Basal Medium Eagles (BME), rinsed once, and treated for
30 min with 10 mg/ml poly-D-lysine. Spinal cords were dissected from
embryonic day 15–18 rat pups and placed into HBSS with 1.26 mM
calcium chloride, 810 mM magnesium sulfate, 10 mM HEPES, 5% fetal
calf serum (FCS), 50 U/ml penicillin, and 50 mg/ml streptomycin on ice.
Spinal cords were then moved to a second dish containing the same
medium in which the DRG were removed with fine forceps. DRG were
transferred to a third dish containing the same medium before plating in
BME supplemented with the following: 5 mg/L human recombinant
insulin, 5 mg/L human transferrin, and 5 ng/L selenous acid (ITS)
(Collaborative Research), 0.2% BSA, 10 mM HEPES, 100 ng/ml 2.5 S
NGF (Collaborative Research) and 1% FCS (BME-ITS-BHN 1% FCS).
Schwann cells derived from these DRG explants have been denoted
SCDRG. Myelinating DRG cultures were established by plating three
ganglia per well in a triangular arrangement in 12 well plates. Cultures
were maintained in a 37°C incubator with 93% air and 7% CO2. Myelin
formation was initiated 7–10 d after infection by changing to myelinating
medium consisting of DMEM-high glucose (H) containing 5.0 gm/L
D-glucose, 2 mM glutamine, 100 ng/ml 2.5S NGF, 15% heat-inactivated
FCS, and 50 mg/ml ascorbic acid (MM1).
Sciatic nerve Schwann cell cultures. Sciatic nerves were removed from
newborn Sprague Dawley rat pups and placed into DMEM-H with 10
mM HEPES (HE) on ice until dissections were complete. The nerves
were treated for 20 min in a gently shaking water bath at 37°C in HE with
0.03% collagenase (Serva Feinbiochemica, Heidelberg, Germany). The
medium was then replaced with the same solution supplemented with
0.25% trypsin and returned to the shaking water bath for 20 min. The
medium was replaced twice with 2.0 ml of DMEM-H 10% FCS, and
the nerves were triturated using a fire-polished glass pipette. The
suspension was plated at a density of two nerves per 9.6 cm 2 plate and
maintained in a 37°C incubator with 95% air and 5% CO2. The
following day, the medium was supplemented to contain 10 mM cyto-
sine b-D-arabinofuranoside (AraC) to kill dividing fibroblasts. After
72 hr, this medium was replaced with fresh medium lacking AraC.
Retroviral vectors. The retroviral vector LiresGFP was derived from the
vector LiresNEO1env (a gift from Dr. Geoff Owens, University of
Colorado Health Sciences Center, Denver, CO). LiresNEO1env was
cut with BstXI and ClaI to remove the neo coding region and the NcoI
site at 2229. An adapter was ligated in its place adding a NotI site to
create the plasmid N-Lires-2. The hGFP(S65T) coding region, obtained
as a NotI fragment from pTRBS-UF2 (Zolotukhin et al., 1996), was
ligated into NotI digested N-Lires-2 to produce LiresGFP.
To create the PKA inhibitory retroviral vector RIaABiresGFP, the
dominant negative regulatory subunit RIaAB was generated by PCR
using plaque-forming units polymerase (Stratagene, La Jolla, CA) and
MTREVAB (a gift from Dr. Stanley McKnight, University of Washing-
ton, Seattle, WA) as a template. The primers BamRIa59 (59-ATA GGA
TCC ACC TGA GAA CCA TGG CGT CTG-39) and RIa39 (59-ATA
GGA TCC TCA GAC GGA CAG GGA C-39) overlapped the translation
initiation codon and the stop codon at the 59 and 39 ends, respectively,
and added BamHI restriction sites flanking the PCR product. The PCR
product was ligated into the BamHI site of LiresNEO1env to produce
RIaABiresNEO. LiresGFP and RIaABiresNEO were cut with XbaI
releasing the iresGFP and iresNEO fragments, respectively. The ires-
GFP fragment was then ligated into the XbaI digested RIaABiresNEO
in place of the analogous iresNEO fragment to produce RIaABiresGFP.
PKIEGFP and EGFP coding sequences were derived from
pTJM2PKIEGFP (Wang and Murphy, 1998). PKIEGFP is a fusion gene
consisting of the full-length rabbit skeletal muscle PKIa fused to the 59
end of the green fluorescent protein EGFP. pTJM2PKIEGFP was mod-
ified by the addition of an adapter 59 of the PKIEGFP coding region
between the HinDIII and SacI sites. The adapter, composed of oligonu-
cleotide DH8-67-3 (59-CAG ATC TTC AAG TTA ACC TGC GGA
TCC A-39) and oligonucleotide DH8-67-4 (59-AGC TTG GAT CCG
CAG GTT AAC TTG AAG ATC TGA GCT-39), added 59-BglII-HpaI-
BamHI-39 restriction sites 59 of the PKIEGFP coding sequence. A
second adapter composed of oligonucleotides DH8-67-1 (59-CTA GGT
AGA TCT TGC-39) and DH8-67-2 (59-GGC CGC AAG ATC TAC-39)
was inserted between the XbaI and NotI sites 39 of the PKIEGFP coding
region, adding a BglII restriction site and producing the plasmid
pTJM2PKIEGFP2. The PKIEGFP coding region was then released by
digestion with BglII and ligated into the BamHI site of LiresNEO to
produce PKIEGFPIN. EGFPIN was constructed from PKIEGFPIN by
digestion with BamHI to release only the PKI coding sequence. The
vector was then religated to produce the control plasmid EGFPIN.
Virus production. GP1E86 cells (Dr. J. Olsen, University of North
Carolina at Chapel Hill, Chapel Hill, NC) (0.5–1.0 3 10 6) were plated in
28.3 cm 2 dishes in DMEM-H 10% FCS and maintained in a 37°C
incubator with 95% air and 5% CO2. The day after plating, the cells were
transfected with 20 mg of plasmid DNA by the calcium phosphate
precipitation method. For LiresGFP and RIaABiresGFP, which lack an
antibiotic selectable marker, cotransfection was performed using a total
of 20 mg of DNA with the viral plasmid and PCDNA3.1 in a 10:1 molar
ratio, respectively. After a 24 hr incubation of the cells with the DNA
precipitate, the medium was replaced. Selection in G418 (400 mg/ml
active) was begun on the second day after transfection. Confluent 176.6
cm 2 plates of packaging cells were maintained in 12 ml of medium with
10 mM n-butyric acid for 3 d, during which time the virus was harvested
and the medium replaced every 24 hr. The harvested medium containing
retroviral vectors was filtered through a 0.45 mm syringe filter before
infections.
Infection protocols. On the third day in culture, DRG explants in 12
well plates were exposed to 1.5–1.75 ml of packaging cell conditioned
medium with 8 mg/ml polybrene for 2 hr at 37°C in a 5% CO2 and 95%
air incubator. Cultures were rinsed twice with BME and returned to
BME-ITS-BHN with 1% FCS. This procedure was repeated on the
fourth and fifth days in culture.
Sciatic nerve Schwann cells were cultured overnight in DMEM-H 10%
FCS with 2 mM forskolin and 40 mg/ml bovine pituitary extract (BPE).
Cells cultured in 28.3 cm 2 dishes were exposed to 4–5 ml of packaging
cell conditioned medium plus 8 mg/ml polybrene for 2 hr in a 37°C
incubator with 5% CO2 and 95% air. Cultures were then rinsed twice in
DMEM-H and returned to DMEM-H 10% FCS with forskolin and BPE.
This procedure was repeated on 3 consecutive days. After the third
infection, cultures were maintained in DMEM-H 10% FCS. Where
appropriate, the cells were selected in DMEM-H 10% FCS with 500
mg/ml G418.
5-Bromo-29-deoxyuridine immunocytochemistry. DRG explant cultures
were treated with 50 mM 5-bromo-29-deoxyuridine (BrdU) for 24 hr in
defined medium (BME-ITS-BHN). Cultures were rinsed once in PBS
and fixed for 10 min at 4°C with 4% paraformaldehyde in PBS, pH 7.3.
Subsequently, cultures were rinsed once in PBS and treated at room
temperature for 10 min with 100% methanol, 20 min with 2N HCl, and
three times for 3 min each with 0.1 M sodium borate buffer, pH 8.5. After
rinsing twice for 5 min each in PBS with 0.5% BSA and 10 mM HEPES,
pH 7.4 (PBS-H-BSA), the primary antibodies [rabbit anti-rGFP IgG,
1:100 (Clontech, Cambridge, UK) and mouse anti-BrdU IgG, 1:50
(Boehringer Mannheim, Indianapolis, IN)] were applied in PBS-H-BSA
for 30 min at 25°C. It was necessary to immunostain for GFP because the
BrdU staining protocol destroyed the GFP chromophore. After three
washes of 5 min each in PBS-H-BSA with 10% normal goat serum,
secondary antibodies [FITC-conjugated goat anti-rabbit IgG, 1:400
(Cappel, West Chester, PA) and rhodamine conjugated goat anti-mouse
IgG, 1:100 (Cappel)] were applied in the same solution for 30 min.
Cultures were rinsed three times for 5 min, once with PBS, and mounted
in PBS/glycerol (50:50).
Sudan black staining. DRG explants were grown in MM1 for 10 d to
promote myelin formation. After fixation for 10 min at room temperature
with 4% paraformaldehyde in PBS, pH 7.4, cultures were osmicated with
0.1% OsO4 in PBS, pH 7.4, for 1 hr and dehydrated in a graded series of
ethanol (25, 50, and 70%; 5 min each). Cultures were then stained with
a solution of 0.5% Sudan black in 70% ethanol for 1 hr at room
temperature, rinsed for ,30 sec in 70% ethanol, rehydrated with PBS,
pH 7.4, and mounted in PBS/glycerol (50:50).
Forskolin stimulation of mitosis. Sciatic nerve Schwann cells infected
with EGFPIN or PKIEGFPIN and selected in G418 were harvested with
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0.2% trypsin and resuspended in DMEM-H 10% FCS. The cells were
plated at low density (;1200 cells per well) into poly-D-lysine-coated 12
well plates. After 24 hr, the medium was changed to DMEM-H 2% FCS
supplemented with the following: (1) nothing; (2) 2 mM forskolin; (3) 40
mg/ml BPE; or (4) 2 mM forskolin and 40 mg/ml BPE. The media were
replaced daily for 5–6 d. The number of Schwann cells in each of ;100
GFP-positive(GFP 1) clones per well was then determined.
For analysis of forskolin-stimulated mitosis using infected SCDRG, a
single DRG was cultured in each well of a 12 well plate and infected as
described above. After infection, cultures were maintained in BME-ITS-
BHN for 2–4 d. Neuronal cell bodies were then removed by aspiration
with a 200 ml pipette tip connected to a vacuum system, and the Schwann
cells were harvested with 0.25% trypsin and a cell scraper. Cells har-
vested from three ganglia were pooled, an equal volume of DMEM-H
10% FCS was added, and cells were aspirated gently with a fire-polished
glass pipette. The suspension was pelleted and resuspended in 100 ml of
the same medium for counting with a hemacytometer. Cells were then
diluted to ;1000 cells/ml in the same medium and plated into six wells of
a glass-bottom poly-D-lysine-coated 12 well plate (1 ml/well). After 48 hr,
the serum was reduced to 2%, and the cells were cultured in the presence
and absence of 2.0 mM forskolin. Media were changed every 2 d for 10 d.
The average number of EGFP 1 (PKIEGFPIN and EGFPIN) or total
(LiresGFP or RIaABiresGFP) Schwann cells per field was determined
by counting Schwann cells in 10 random fields (0.29 cm 2 each) per
coverslip.
Forskolin effects on morphology. DRG explants were cultured and
infected as described for forskolin stimulation of SCDRG mitosis. For
each virus, the Schwann cells harvested from three wells were pooled,
pelleted, resuspended in 6 ml of DMEM-H 10% FCS, and plated into six
wells of a glass-bottom 12 well plate (1 ml/well). After 48 hr, the medium
was changed to DMEM-H 10% FCS with or without 2.0 mM forskolin.
Media were replaced every 2 d for 4–6 d to promote morphological
change.
Sciatic nerve Schwann cells were infected on 3 consecutive days with
the retroviral vector EGFPIN or PKIEGFPIN and selected in G418.
Infected cells were harvested with trypsin and replated into 12 well plates
in DMEM-H 10% FCS (;10 4 cells per well). After 24 hr the medium
was replaced with DMEM-H 10% FCS with or without 2 mM forskolin.
Cultures were maintained in these media for 4–6 d, with media changed
every other day.
Neuronal stimulation of mitosis. DRG explants were maintained and
SCDRG-infected as described above. On the seventh day in culture (2 d
after infection), the culture medium was supplemented with BrdU (50
mM). After a 24 hr pulse with BrdU, cultures were processed for GFP and
BrdU immunocytochemistry as described above. For EGFPIN- and
PKIEGFPIN-infected cells, the percentage of BrdU 1 cells of 100–200
GFP 1 cells was determined for each coverslip. For LiresGFP- and
RIaABiresGFP-infected cells, the percentage of BrdU 1 cells in a ran-
dom population of 100–200 cells per coverslip was determined. This was
necessary because the signal after immunocytochemical detection of
GFP in cells infected with LiresGFP or RIaABiresGFP was often too
low to permit confident distinction between cells that were and cells that
were not expressing GFP.
The effects of chemical inhibitors of PKA on neuronal stimulation of
mitosis were also examined. Noninfected DRG explant cultures were
exposed to H-89 (10 mM) or KT5720 (1–10 mM) for 48 hr on the sixth and
seventh days in culture. The media were replaced with fresh PKA
inhibitors and 50 mM BrdU for the final 24 hr. Cultures were then fixed
and immunostained for BrdU as described above. In all cases, analysis
was limited to the periphery of the cultures in which Schwann cell density
was lowest to avoid contact inhibition of Schwann cell mitosis.
RESULTS
Infection with PKA inhibitory retroviral vectors blocks
forskolin-stimulated Schwann cell mitosis and
morphological change
We have created two control (EGFPIN and LiresGFP) and two
PKA inhibitory (RIaABiresGFP and PKIEGFPIN) retroviral
vectors (Fig. 1). The small amount of Schwann cell protein (,20
mg) obtained from infected preparations prevented the use of
traditional in vitro biochemical assays to directly evaluate the
inhibition of PKA in infected Schwann cells. However, elevation
of cAMP in Schwann cells has been shown previously to syner-
gistically stimulate mitosis in the presence of growth factors and
to cause a dramatic morphological change in Schwann cells. We
used the adenylyl cyclase activator forskolin to stimulate mitosis
and morphological changes in infected Schwann cells as indirect
bioassays to test the ability of the retroviral vectors
RIaABiresGFP and PKIEGFPIN to inhibit PKA.
Sciatic nerve Schwann cells were infected with the control
vector EGFPIN or the PKA inhibitory vector PKIEGFPIN,
resulting in striking GFP expression in ;70% of the Schwann
cells. Low-density cultures of infected Schwann cells were grown
for 4 d in 2% FCS medium, or 2% FCS medium with 2 mM
forskolin, 40 ng/ml bovine pituitary extract, or both. The number
of Schwann cells in GFP1 clones was then determined. Infection
with PKIEGFPIN completely blocked Schwann cell mitosis stim-
ulated by forskolin but had no effect on mitosis stimulated by
bovine pituitary extract (Fig. 2).
The majority of our studies use the DRG explant system to
isolate Schwann cells and examine neuron–Schwann cell interac-
tions. The protocol used to infect SCDRG differed significantly
from that used to infect sciatic nerve Schwann cells. Therefore,
the retroviral vectors LiresGFP, RIaABiresGFP, EGFPIN, and
PKIEGFPIN were also examined for their ability to block
forskolin-stimulated mitosis and morphological changes in
SCDRG. SCDRG were infected with a control vector (LiresGFP or
EGFPIN) or a PKA inhibitory vector (RIaABiresGFP or
PKIEGFPIN), resulting in visible GFP expression by .90% of
the SCDRG (Howe and McCarthy, 1998). After infection and 3–5
d of expansion on the bed of DRG neurites, the Schwann cells
were replated at low density and grown for 10 d in medium with
Figure 1. Structure of recombinant retroviruses for inhibition of PKA.
The retroviral 59 long-terminal repeat (LTR) drives expression of the
encoded genes in infected cells. Control vectors have nothing (LiresGFP)
or EGFP (EGFPIN) cloned 59 of the encephalomyocarditis virus ires.
PKA inhibitory vectors have either the dominant negative PKA regula-
tory subunit RIaAB (RIaABiresNeo) or PKIEGFP (PKIEGFPIN)
cloned 59 of the ires. 39 of the IRES is either GFP(S65T) (GFP) or the
neomycin resistance gene (NEO).
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2% FCS in the presence or absence of 2 mM forskolin. The
number of EGFP1 (EGFPIN and PKIEGPIN) or total (Lires-
GFP and RIaABiresGFP) SCDRG in 10 random fields (0.29 cm
2
each) per culture was determined. The high percentage of cells
that were infected by LiresGFP and RIaABiresGFP permitted
analysis of the total population as opposed to focusing only on the
GFP1 cells. Stimulation with forskolin (2.0 mM) increased the
average number of EGFPIN- or LiresGFP-infected SCDRG from
2–3 to 40–60 cells per field. In contrast, only 2–5 cells per field
were observed in PKIEGFPIN- or RIaABiresGFP-infected
cells, even when stimulated with forskolin (Fig. 3). These findings
demonstrate that retroviral delivery of either the PKA dominant
negative regulatory subunit RIaAB or the PKA inhibitor
PKIEGFP effectively blocks forskolin-stimulated Schwann cell
mitosis and strongly suggest that PKA is functionally inhibited in
Schwann cells infected with PKA inhibitory retroviral vectors.
Elevation of cAMP causes Schwann cells to change from a
spindle-shaped to a flattened morphology with fenestrated cyto-
plasmic expansions (Sobue et al., 1986; Morgan et al., 1991). The
ability of forskolin to cause this morphological change in infected
SCDRG was examined as a second indirect evaluation of PKA
activity in infected Schwann cells. Infected SCDRG were har-
vested, replated at low density, and exposed to 2 mM forskolin for
4 d in 10% FCS. SCDRG infected with EGFPIN exhibited a
spindle-shaped morphology in the absence of forskolin and a
flattened morphology in the presence of forskolin (Fig. 4A,B,
respectively). SCDRG infected with PKIEGFPIN also exhibited a
spindle-shaped morphology in the absence of forskolin but did
not demonstrate any morphological change in response to treat-
ment with forskolin (Fig. 4C,D, respectively). Similar results were
obtained with SCDRG infected with LiresGFP or RIaABiresGFP,
as well as sciatic nerve Schwann cells infected with EGFPIN and
PKIEGFPIN (data not shown). Overall, these results strongly
suggest that infection of sciatic nerve Schwann cells or SCDRG
with PKIEGFP or RIaABiresGFP functionally blocked PKA-
dependent signaling.
Inhibition of Schwann cell PKA does not inhibit
neuronal stimulation of Schwann cell mitosis
To test the role of Schwann cell PKA in the neuronal stimulation
of Schwann cell mitosis, DRG explants were exposed to chemical
inhibitors of PKA, as well as PKA inhibitory retroviral vectors.
H-89 (10 mM) or KT5720 (1–10 mM), chemical inhibitors selective
for PKA (Kase et al., 1987; Chijiwa et al., 1990), were applied to
noninfected DRG explants for 48 hr starting on the sixth day in
culture. Fresh medium and inhibitor with BrdU (50 mM) were
added for the last 24 hr. Incorporated BrdU was detected by
immunocytochemistry. Approximately 70% of the control SCDRG
were BrdU1 (Fig. 5). H-89 (10 mM) reduced the percentage of
BrdU1 Schwann cells to 30% (Fig. 5), a result in agreement with
that of Kim et al. (1997). KT5720 (10 mM) had a similar effect,
reducing the percentage of BrdU1 SCDRG to ,10% (Fig. 5). In
marked contrast to the results obtained with H-89 and KT5720,
inhibition of PKA in SCDRG by infection with PKIEGFPIN or
RIaABiresGFP had no effect on the neuronal stimulation of
Schwann cell mitosis (Fig. 5).
Inhibition of Schwann cell PKA inhibits
myelin formation
Elevation of cAMP promotes expression of a myelin-related
phenotype in Schwann cells (Morgan et al., 1991). In addition,
Figure 2. Infection of sciatic nerve Schwann cells with PKIEGFPIN
blocks forskolin-stimulated but not BPE-stimulated Schwann cell mitosis.
Sciatic nerve Schwann cells were infected with the retroviral vectors
EGFPIN or PKIEGFPIN and selected in G418. The infected population
was then plated at low density in a 12 well plate in medium with 10%FCS.
After 24 hr, the medium was changed to 2% FCS (Control ) in the
presence of 2 mM forskolin (FSK ), 40 mg of BPE, or both (FSK/BPE).
Cultures were maintained for 4 d in each condition. The number of cells
in each of ;100 GFP 1 clones per well was then determined. Significance
of differences from three independent experiments was determined by a t
test (n 5 3; *p , 0.02; **p , 0.002).
Figure 3. Infection of Schwann cells expanding from DRG explants with
PKIEGFPIN or RIaABiresGFP blocks forskolin-stimulated Schwann
cell mitosis. Schwann cells expanding from DRG explants were infected
on 3 consecutive days with the retroviral vector LiresGFP, EGFPIN,
RIaABiresGFP, or PKIEGFPIN. After a brief period of expansion on
neurites, the Schwann cells were replated at low density and maintained
for 8 d in medium with 2% FCS in the presence or absence of 2 mM
forskolin. The number of GFP 1 (EGFPIN and PKIEGFPIN) or total
(LiresGFP and RIaABiresGFP) Schwann cells per 0.29 cm 2 field was
determined in 10 random fields per coverslip. Forskolin stimulation
caused an extensive mitotic response in Schwann cells infected with the
control vectors LiresGFP and EGFPIN. In contrast, forskolin-stimulated
mitosis was completely inhibited in Schwann cells infected with the PKA
inhibitory retroviral vectors RIaABiresGFP and PKIEGFPIN. Data are
the mean 6 SD from three independent experiments. Significance of
differences was determined with a t test (n 5 3; *p , 0.005).
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neuronal contact and myelination are correlated with the eleva-
tion of cAMP levels in myelinating nerves by regulation of
Schwann cell adenylyl cyclase and phosphodiesterase activities
(Poduslo et al., 1995; Walikonis and Poduslo, 1998). These re-
ports suggest that elevation of Schwann cell cAMP and activation
of PKA may be an important signal in the initiation or mainte-
nance of myelination by Schwann cells. The involvement of
Schwann cell PKA in myelination was examined using SCDRG
infected with PKA inhibitory retroviral vectors. Infected SCDRG
were maintained in MM1 for 10 d to promote myelin formation.
After 4–5 d in MM1, structures resembling the initial stages of
myelination were clearly visible in the EGFP-expressing cultures,
whereas such structures were virtually absent from PKIEGFP-
expressing cultures. Myelin appeared as long stretches of parallel
EGFP1 Schwann cell profiles. By 7 d in MM1, myelin segments
were clearly visible on examination of EGFPIN-infected cultures
under phase optics. Frequently, these myelin segments were
EGFP1 on examination under epifluorescence (Fig. 6A,B). In
contrast, little myelin formation was observed in PKIEGFPIN-
infected cultures on examination with phase-contrast microscopy,
and PKIEGFP1 myelin segments were virtually absent on exam-
ination with epifluorescence microscopy (Fig. 6C,D). In
LiresGFP- and RIaABiresGFP-infected cultures, many Schwann
cells were clearly expressing GFP. However, low ires-mediated
GFP expression and high cell density precluded accurate deter-
mination of whether the myelin was elaborated by infected
SCDRG. To quantify the myelin segments produced by infected
Schwann cells, cultures were stained with Sudan black after 10 d
in MM1. On examination with phase-contrast microscopy,
a marked overall decrease in the density of myelin segments
was observed in cultures infected with PKIEGFPIN or
RIaABiresGFP compared with EGFPIN or LiresGFP (Fig. 7A).
Schwann cell bodies associated with Sudan black-stained myelin
segments were counted over the entire area of cultures. Infection
with PKIEGFPIN or RIaABiresGFP resulted in an 80% reduc-
tion in the total number of myelin segments per coverslip com-
pared with cultures infected with the control vectors EGFPIN or
LiresGFP (Fig. 7B).
DISCUSSION
Neuron–Schwann cell interactions are critical for proper devel-
opment and regeneration of the peripheral nervous system. Many
reports document that neuronal contact and cAMP elevation
have similar effects on Schwann cell mitosis and the expression of
myelin-associated molecules, suggesting that neuronal contact
may exert its effects by elevating Schwann cell cAMP. Therefore,
we wished to test the hypothesis that activation of Schwann cell
PKA is necessary for the neuronal stimulation of Schwann cell
mitosis and myelin formation. To achieve this, retroviral vectors
were used to deliver genes encoding highly specific PKA inhibi-
tory proteins selectively to Schwann cells cocultured with
neurons.
The retroviral vectors we describe use a dicistronic design to
facilitate inhibition of PKA and identification of infected cells.
Two variants of GFP have been used to identify infected cells.
The vectors LiresGFP and RIaABiresGFP use GFP(S65T) 39 of
the ires. Translation of coding sequences 39 of an ires can be
comparable with or significantly less than the 59 cap-mediated
expression of an upstream coding sequence. Consequently, a
direct correlation between the intensity of the GFP and the level
Figure 4. Infection of Schwann cells expanding from DRG explants with
PKIEGFPIN blocks forskolin-stimulated Schwann cell morphological
changes. Schwann cells expanding from DRG explant cultures were
infected on 3 consecutive days with the retroviral vectors EGFPIN or
PKIEGFPIN. Infected Schwann cells were replated and grown in 10%
FCS in the absence (A, C) or presence (B, D) of 2 mM forskolin for 4 d.
Infection of Schwann cells with PKIEGFPIN completely blocked the
ability of forskolin to stimulate a morphological change. Similar observa-
tions were made with SCDRG infected with LiresGFP or RIaABiresGFP.
Scale bar, 100 mm.
Figure 5. Inhibition of PKA selectively in Schwann cells does not inhibit
neuronal stimulation of Schwann cell mitosis. SCDRG were left uninfected
or infected with the retroviral vectors LiresGFP, RIaABiresGFP,
EGFPIN, or PKIEGFPIN. Beginning on the sixth day in culture, non-
infected neuron–Schwann cell cocultures were exposed to H-89 (10 mM)
or KT5720 (1, 5, or 10 mM) for a total of 48 hr. On the seventh day in
culture, medium on infected cultures, noninfected control cultures, and
noninfected cultures exposed to inhibitors were supplemented to contain
50 mM BrdU in the presence or absence of H-89 or KT5720 for 24 hr. The
percentage of Schwann cells that were BrdU 1 was then determined by
immunocytochemical detection of BrdU-labeled cells. Data are the
mean 6 SD of three independent experiments. Significance of differences
was determined with a t test (n 5 3; *p , 0.02; **p , 0.005).
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of RIaAB expression cannot be made. Low-intensity GFP ex-
pression therefore does not necessarily indicate low expression
levels of RIaAB. In contrast, PKIEGFPIN and EGFPIN use a
significantly brighter GFP variant (EGFP). EGFP is fused to
PKI, and PKIEGFP expression is independent of an ires. These
changes resulted in expression of PKIEGFP that was easily
detected visually and the intensity of which should be directly
correlated with the level of PKI and thus PKA inhibition. Be-
cause both PKIEGFPIN and RIaABiresGFP had dramatic and
equivalent effects in all experiments, we feel that the expression
level achieved by both of these vectors was sufficient to function-
ally inhibit PKA.
Traditionally, in vitro assays are performed to evaluate PKA
activity in cell extracts. The limited amount of protein available
from infected Schwann cell minicultures did not permit this type
of in vitro biochemical analysis. Expansion of infected Schwann
cells with forskolin and growth factors was not attempted, be-
cause this is a PKA-dependent process and was inhibited by our
PKA inhibitory retroviral vectors. Experiments examining
cAMP response element-binding protein (CREB) phosphoryla-
tion were performed in an attempt to demonstrate more directly
the effect of the PKA inhibitory retroviral vectors on Schwann
cell PKA. Unfortunately, CREB phosphorylation was not de-
tected in Schwann cells after treatment with either forskolin or
bovine pituitary extract. These experiments were performed us-
ing immunocytochemical methods and phosphoCREB antibodies
obtained from two different commercial sources. Elevation of
Schwann cell cAMP enhances stimulation of mitosis by several
growth factors (Davis and Stroobant, 1990; Weinmaster and
Lemke, 1990; Stewart et al., 1991) and induces significant mor-
phological changes (Sobue et al., 1986; Muir et al., 1989).
Forskolin-stimulated mitosis and morphological change were thus
used as indirect functional assays to assess PKA activity in
infected Schwann cells. Infection of Schwann cells with PKA
inhibitory retroviral vectors completely blocked the ability of
forskolin to stimulate Schwann cell mitosis evaluated by measures
of cell density, as well as by counting the size of individual
Schwann cell clones. In experiments with Schwann cell clones,
examination of the cultures shortly after plating at low density
Figure 6. Myelin formed in EGFPIN-infected cultures is visible on
examination under phase and epifluorescence. SCDRG were infected with
EGFPIN or PKIEGFPIN on 3 consecutive days in culture. After ;10 d
of expansion on neurites in defined medium, cultures were grown in
MM1 for 10 d. Myelin was a prominent feature of EGFPIN-infected
cultures and was clearly visible on examination using either epifluores-
cence (A) or phase-contrast (B) microscopy. In contrast, myelin forma-
tion was markedly reduced in PKIEGFPIN-infected cultures examined
with both epifluorescence (C) and phase-contrast (D) microscopy.
Arrows indicate the relative position of myelin segments in each pair of
photographs. The myelinating Schwann cell in C and D is the only
example we observed of a PKIEGFP-expressing Schwann cell that ap-
peared to have initiated myelination. Scale bar, 25 mm.
Figure 7. Infection of Schwann cells expanding from DRG explants with
PKIEGFPIN or RIaABiresGFP inhibits myelin formation. Schwann
cells expanding from DRG explants were infected with the retroviral
vectors EGFPIN, PKIEGFPIN, LiresGFP, or RIaABiresGFP. A, After
10 d in MM1 to promote myelin formation, cultures were stained with
Sudan black. B, Schwann cell bodies associated with Sudan black-stained
myelin segments were counted over the entire surface area of each
coverslip. Within each experiment, the number of myelin segments
formed in cultures infected with PKIEGFPIN or RIaABiresGFP was
normalized to that in EGFPIN or LiresGFP control cultures, respec-
tively. The data are the mean 6 SD of three independent experiments.
Significance of differences was determined by a one-sample t test (n 5 3;
*p , 0.0025).
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indicated that the vast majority of the cells were isolated as single
cells. However, it is possible that a small percentage of the cell
clusters examined originated from more than one infected
Schwann cell. The low frequency with which this may have oc-
curred is not likely to have affected the results. Morphological
changes caused by treatment of Schwann cells with forskolin were
also completely blocked by infection of Schwann cells with PKA
inhibitory but not control retroviral vectors. These results
strongly indicate that signaling through PKA is substantially
inhibited in Schwann cells infected with PKIEGFPIN or
RIaABiresGFP.
The importance of Schwann cell PKA in neuronal stimulation
of Schwann cell mitosis was evaluated with chemical and retro-
viral inhibitors of PKA. H-89 and KT5720 significantly inhibited
neuronal stimulation of Schwann cell mitosis, consistent with the
data of Kim et al. (1997). However, this approach results in PKA
inhibition in both neurons and Schwann cells. In contrast to the
results with chemical inhibitors, inhibition of PKA in Schwann
cells by infection with PKA inhibitory retroviral vectors had no
effect on neuronal stimulation of Schwann cell mitosis. One
possibility that cannot be completely ruled out is that the PKA
inhibitory proteins were not expressed at a high enough level to
inhibit Schwann cell mitosis stimulated by interaction with neu-
rons. We feel that this is unlikely for several reasons. Both PKA
inhibitory vectors essentially prevented myelination, demonstrat-
ing their ability to block a complex neuron-mediated effect on
Schwann cells. In addition, both PKA inhibitory vectors com-
pletely blocked the ability of forskolin to stimulate Schwann cell
mitosis and morphological changes yet had a complete lack of
effect on neuronal stimulation of mitosis. The profound effect of
these vectors on myelination and on the ability of forskolin to
stimulate Schwann cell mitosis and morphological change
strongly suggests that they inhibited PKA activity to a significant
extent. Both PKI and RIaAB have subnanomolar Kd values for
PKA, demonstrating the high affinity of their association and thus
their high potency (Hofmann, 1980; Scott et al., 1986; Herberg
and Taylor, 1993). Once bound to the PKA catalytic subunit,
RIaAB is stabilized and sequesters catalytic subunits. This mech-
anism is thought to play an important role in the potent effect of
RIaAB, even when expressed at low levels (Corell et al., 1989).
One possibility consistent with our observations is that H-89 and
KT5720 are exerting their effects on Schwann cell mitosis by
inhibition of PKA in neurons. Chemical inhibitors of PKA affect
the development of neurites from PC12 cells and cultured hip-
pocampal neurons, raising the possibility that these inhibitors may
prevent neurons from delivering the mitogenic signal to Schwann
cells (Chijiwa et al., 1990; Cabell and Audesirk, 1993). The
possible role of neuronal PKA in modulating Schwann cell phe-
notype will be an interesting area for further investigations.
An additional consideration is the specificity of the inhibitors.
Both H-89 and KT5720 are competitive with ATP for binding to
the PKA catalytic subunit and therefore may have non-PKA-
dependent effects in common (Kase et al., 1987; Chijiwa et al.,
1990). At least one report documents inhibition of Schwann cell
mitogen-activated protein kinase (MAPK) in intact cells by
KT5720, finding that KT5720 has an IC50 of 1.0 mM for MAPK,
5.8 mM for PKC, 3.7 mM for cdc2, and 1.4 mM for PKA (Olsen et
al., 1998). The neuronal stimulation of Schwann cell mitosis is
mediated by neuregulin stimulation of ErbB receptors on
Schwann cells (Levi et al., 1995; Morrissey et al., 1995). Because
MAPK is a downstream effector of activated ErbB receptors,
inhibition of MAPK by KT5720 is one possible explanation for
the ability of this inhibitor to block neuronal stimulation of
Schwann cell mitosis. The inability of PKA inhibitory retroviral
vectors to inhibit neuronal stimulation of Schwann cell mitosis is
consistent with this possibility. PKI and RIaAB are highly spe-
cific for PKA, and no direct inhibition of the MAPK pathway
would be expected.
It has been reported recently that both b-neuregulin and neu-
ronal contact induce sustained phosphorylation of CREB at
serine 133 (Tabernero et al., 1998; Lee et al., 1999). This
b-neuregulin-induced CREB phosphorylation is mediated at
least in part via activation of the MAPK pathway. Rahmatullah et
al. (1998) reported activation of extracellular signal-regulated
kinase (ERK) and ERK2 in Schwann cells after exposure to
b-neuregulin, and Tabernero et al. (1998) reported that
b-neuregulin-induced CREB phosphorylation was reduced by
treatment with the MAPK kinase inhibitor PD98059. However,
sustained CREB phosphorylation and Schwann cell division were
only observed when cells were exposed to both elevation of
cAMP and b-neuregulin (Rahmatullah et al., 1998). These re-
ports suggest that maximal stimulation of Schwann cell mitosis
requires both activation of MAPK and cAMP-dependent signals
in Schwann cells. Our results suggest that neuronal stimulation of
Schwann cell mitosis does not require activation of cAMP-
dependent protein kinase in Schwann cells. These data raise the
possibility that agents that increase cAMP facilitate phosphory-
lation of CREB and mitogenic signaling in Schwann cells via a
PKA-independent mechanism. The recently described family of
cAMP-binding guanine nucleotide exchange factors (cAMP-
GEFs) provide one possible mechanism by which agents that
elevate cAMP could facilitate signaling in the MAPK pathway.
cAMP-GEFs were shown recently to bind cAMP and directly
activate Rap1A in a cAMP-dependent and PKA-independent
manner (Kawasaki et al., 1998). Rap1 is known to activate the
MAPK pathway via its interaction with B-Raf (Ohtsuka et al.,
1996; York et al., 1998). The possibility that cAMP-GEFs play an
important role in neuron–Schwann cell interactions will be an
interesting area for further investigations.
Many reports have documented that neuronal contact with
Schwann cells can induce myelin formation. We addressed the
importance of Schwann cell PKA in myelin formation using
SCDRG infected with PKA inhibitory retroviral vectors. Schwann
cells expressing the PKA inhibitory proteins PKIEGFP or
RIaAB failed to myelinate DRG neurons. In comparison, GFP1
myelin segments were abundant in LiresGFP- and EGFPIN-
infected control cultures, strongly suggesting that activation of
PKA is an important event in the process of myelination by
Schwann cells. This result further supports our contention that
PKA activity was significantly inhibited in Schwann cells infected
with RIaABiresGFP or PKIEGFPIN. It is clear that Schwann
cell cAMP levels are elevated in myelinating nerves by modula-
tion of adenylyl cyclase and phosphodiesterase activities (Poduslo
et al., 1995; Walikonis and Poduslo, 1998). P0 gene induction
occurs before cAMP elevation in regenerating sciatic nerve en-
doneurial explants, and cAMP levels reached only 27% of control
values by 35 d after a crush injury, a time when the remyelination
process is virtually complete (Poduslo et al., 1995). The results of
these studies demonstrate that elevation of cAMP occurs in
actively myelinating but not nonmyelinated nerves and that ex-
pression of at least some myelin proteins may be independent of
cAMP elevation. However, these results do not preclude the
possibility that cAMP and PKA play an important role in the
formation or stabilization of myelin sheaths. Additionally, it is
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difficult to account for the possible effects of subcellular localiza-
tion of cAMP and PKA. Perhaps the relatively low level of
cAMP present in regenerating nerves is sufficient to support an
important role for cAMP and PKA in the process of myelination.
Our results suggest that activation of Schwann cell PKA is an
important step in the process of myelin formation or stabilization.
We do not know the stage at which PKA inhibitory retroviral
vectors block myelination. Possibilities include a failure to be-
come quiescent, form a proper basal lamina, execute morpholog-
ical changes, or express transcription factors, proteins, or lipids
required for myelin formation. These will be areas of interest to
examine in future studies using the retroviral approach we have
taken here or through the use of transgenic and knock-out tech-
niques in mice.
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